Novel analogs of acyclic nucleosides based on a bis-hydroxymethylphosphinic acid (BHPA) backbone were incorporated into a thymidine-containing DNA strand by phosphoramidite methodology. The physicochemical properties of these constructs were evaluated. Melting temperature measurements demonstrate that chimeric oligomers with a phosphinate / phosphate backbone possess lower binding affinity towards complementary single stranded templates and slightly higher binding affinity towards double stranded DNA, as compared to non-modified reference oligomers. The polyanionic oligomers containing BHPA abasic residue were also synthesized by the same methodology. These oligomers show low cytotoxic activity toward HUVEC and HeLa cell lines and, as expected, are resistant to nucleolytic degradation at the modification site.
Introduction
DNA analogs with improved stability to nucleolytic degradation and higher binding affinity toward complementary DNA or RNA strands are of interest due to their potential application as therapeutics in antisense 1 or antigene strategies. 2 Several acyclic analogs of DNA, including those derived from isosteric glyceronucleosides, have been synthesized for these purposes up to now. 3, 4 Despite their improved flexibility those oligomers in most cases form weaker duplexes with complementary DNA or RNA strands, except in the case when increasing flexibility of the carbohydrate portion resulted in triplex stability.
The aim of reported studies was the design of novel antisense / antigene therapeutics based on the use of a bis-(hydroxymethyl)phosphinic acid (BHPA) unit as a scaffold molecule. We assumed that bis-(hydroxymethyl)phosphinic acid could replace the 3'-, 4'-and 5'-carbons of the sugar moiety and provide a site for attachment of nucleobases via a one-or two-carbon linker. Esterified or amidated BHPA, if successfully incorporated into the oligonucleotide chain, were expected to possess an additional hydrogen bond acceptor site at the phosphinyl oxygen atom. The conformational flexibility and neutral nature of such a unit as in 2 could enhance cellular uptake, while attached nucleobases were expected to interact via stacking and hydrogen bonds with complementary DNA or RNA. Moreover, it was anticipated that even an abasic bis-(hydroxymethyl)phosphinic unit, as in 1, could provide protection of chimeric constructs against nucleolytic degradation. The use of a bis-(hydroxymethyl)phosphinic acid for the synthesis of acyclic nucleoside analogs and their successful incorporation into short DNA oligomers has been disclosed. 6 Such acyclic nucleoside analogs were successfully used for the protection of deoxyribozymes, directed towards the HIV-1 viral RNA sequence in in vitro HIV-1 infected cellular experiments, 7 as well as for deoxyribozymes designed to cleave bcr-abl mRNA fragments in in vitro experiments. 8 In this paper we report on the synthesis of longer oligomers with a chimeric phosphinate / phosphate backbone and the evaluation of the biophysical properties of such constructs, including their affinity toward RNA and DNA templates, their stability in the presence of 3'-and 5'-exonucleases, and their cytotoxic activity in selected cell lines. mesitylenesulfonyl)-3-nitro-1,2,4-triazole (MSNT) as activator. To obtain 7c and 7d, phosphinate 6 was subjected to an Appel-type reaction with N-1-or N-3-(2-aminoethyl)thymine. This reaction was carried out in pyridine in the presence of triphenylphosphine (3 eq.) and carbon tetrachloride (5 eq.). The yields of the desired products were rather low (25-30 %). Physicochemical characteristics of compounds 7a-d are presented in Table 1 . The derivatives 7a-d were subsequently subjected to selective removal of one DMT group by short treatment with toluene-4-sulfonic acid in methanol (0.02 M, 0.8 eq.). The reaction had to be stopped after 5-6 min while ca. 60 % of substrate was still present in the reaction mixture. Extended reaction times led to significant amounts of fully deprotected BHPA ester or amide derivatives resulting from their further decomposition due to P-O and P-N bond cleavage. Therefore, the reactions were terminated by addition of an excess of pyridine. The desired products were isolated by means of preparative TLC with recovery of ca. 60 % of starting material. This procedure could be repeated until the entire substrate was deprotected affording the desired 8a-d in ca. 30-35 % yield. Compounds 8a-d, containing P-chiral center, were used as racemic mixtures for further transformations. Phosphitylation 13 of the free OH group in 8a-d by means of O-2-cyanoethyl-N,N,N',N'-tetraisopropylphosphordiamidite (1.2 eq.) was carried out in anhydrous acetonitrile in the presence of 2-ethylthio-1H-tetrazole (2.4 eq.) providing the acyclic nucleoside phosphoramidite synthons 9a-d.
manufacturer was a prolonged coupling time of the modified monomers (up to 600 s). The coupling efficiency of 9a-d, as determined by DMT-ion assay, was in the range of 95-97 %. The 5'-terminal DMT group was usually removed before cleavage of the product from the solid support.
While the synthesis of trimers dApYpdC 10 (where Y is a modified BHPA unit as in 2, B = thymin-1-yl or thymin-3-yl, n=2) followed by a standard ammonia deprotection and RP HPLC purification led to the desired amidate derivatives 10c and 10d, this approach did not yield the esterified derivatives 10a and 10b (Table 2 , a-d as in Scheme 1). Instead, as revealed by MALDI-TOF analysis, both isolated products in fact constituted the same compound 11, possessing a BHPA unit with depleted alkyl-nucleobase moiety (Y  ab , see table 2 ). In this case hydrolytic deprotection conditions (concentrated aqueous ammonia, 16 h, 55 °C) resulted in cleavage of the ester bond of the phosphinic acid derivatives 10a and 10b, giving rise to anionic DNA analogs with a pseudo-abasic site (as presented in the structure 1). This instability of the BHPA ester bond of 10a and 10b was also observed under less harsh conditions, routinely used for the cleavage of oligomers from the solid support (28 % aq. NH 4 OH, 1 h, 20 °C). Despite the observed stability of the ester bond of 7a and 7b in concentrated aqueous ammonia (2 h at RTdata not shown), we considered that such compounds, as base-labile phosphotriester analogs, 16 might not survive the deprotection conditions during DNA synthesis. This result, albeit expected for those phosphotriester analogs, 17 convinced us that the routine phosphoramidite methodology could not be used for the synthesis of the modified oligomers containing nucleotide units with required protection of nucleobases. However, application of an oxalyl-LCA CPG solid support 15 and methyl-phosphoramidite methodology 14 allowed us to obtain homo-thymidylates TpTpYpYpTpT (12a and 12b). 6 Removal of the phosphate protecting methyl groups was achieved by treatment of solid support-bound oligomers with a thiophenol / dioxane / triethylamine mixture (2:1:2, v/v) for 5 min at RT, followed by the release of oligomers from the solid support by treatment with 1 % aqueous triethylamine for 7-10 min at RT. Expected oligomers were also obtained by using an oxalyl-LCA CPG solid support and protection of the phosphate function with a 2-cyanoethyl group. In this case treatment of solid support-bound oligomers with 1 % aqueous triethylamine for 10 min at room temperature resulted in simultaneous release of the oligomer and removal of the 2-cyanoethyl protecting groups. The basic conditions used were sufficient for release of the oligomer from the solid support without hydrolytic cleavage of the P-O bond. Chimeric oligomers 10 and 12 were synthesized as diastereomeric mixtures by virtue of a chiral center at the phosphorus atom of the BHPA moiety. In spite of our efforts neither trimers 10c and 10d nor hexamers 12a and 12b could be separated by HPLC in the form of P-chiral pure diastereomers.
Substrates for the synthesis of abasic DNA analogs A much simpler synthetic route to the anionic DNA analogs 1 could be used starting from bis-(hydroxymethyl)phosphinic acid methyl ester 4. Dimethoxytritylation of one of OH groups in 4 followed by phosphitylation of the resulting 8e led to phosphoramidite monomer 9e (Scheme 2). Monomer 9e could be used for the synthesis of pseudo-abasic DNA analogs, either those possessing a Y ab group within the oligomer chain, or at the 5'-end of the construct. For introduction of the abasic BHPA unit at the 3'-end of the oligomer derivative 8e was acylated with succinic anhydride in pyridine and then coupled with an aminoalkyl linker of controlled pore glass solid support (LCA CPG). This modified solid support 9f was loaded with the BHPA derivative up to 57.0 µmol /g, as determined by a DMT-cation assay and used for the synthesis of 3'-modified chimeric DNA analogs.
Synthesis of longer chimeric DNA analogs -compounds 13-21
Our preliminary experiments led us to the following conclusions:
• the routine phosphoramidite strategy has proved to be successful for the synthesis of the short chimeric oligomers containing BHPA amidate units; • esterified BHPA analogs can be introduced only into homo-thymidylate oligomers exclusively via an oxalyl-linked solid support approach;
• anionic abasic analogs of DNA can be obtained from an easily accessible monomer (DMT protected phosphoramidite of BHPA methyl ester) 4.
Therefore, this methodology was used for the synthesis of numerous longer oligomers with phosphinate / phosphate backbone. Monomers 9a and 9c, mimicking acyclic DNA nucleosides (N-1-substituted thymine), were used for the synthesis of nonadecathymidylate analogs 19, 20 and 21, containing incorporated one, two or three BHPA units, respectively.
Oligonucleotides 19a-21a, possessing esterified BHPA units, due to their rather low stability either in basic and acidic conditions, were obtained as fully deprotected oligomers. The yields of these oligomers, after RP HPLC separation, were rather moderate (10-15 optical units from 1 µmol DNA synthesis).
For the synthesis of oligomers 19c-21c containing BHPA amidate units we used a two step deprotection / purification procedure. 19 After the synthesis was completed, oligomers 19c-21c
were released from the solid support as the 5′-DMT-protected derivatives. Shorter by-product oligomers were separated chromatographically from the desired, DMT-containing hydrophobic oligomers, which then were exposed to acidic conditions (3 % TFA in dichloromethane). These conditions were safe during the automated synthesis of oligomers and were supposed to be suitable for final deprotection of the terminal 5′-OH group of 19c-21c. Unfortunately, all our efforts to obtain the desired fully deprotected oligomers without cleavage of the P-N bond have failed, even if the time of the reaction was as long as required for the removal of the DMT group during the DNA solid phase synthesis. Thus, we concluded that the removal of the 5'-terminal DMT protecting group should be carried out before the release of the oligomer from the solid support, as we proved by the successful synthesis of the trimer dApYpdC 10c. 6 No other methods of removal of DMT group as e.g. using ZnBr 2 20 were tested.
For evaluation of biophysical properties oligomers 19a-21a were used as fully deprotected species, and oligomers 19c-21c as 5′-DMT-protected constructs. The structures of all oligomers listed in Table 2 were confirmed by MALDI-TOF mass spectrometry, and their purity was confirmed by HPLC analysis. As determined by analytical RP HPLC the purity of oligomers 19-21 was ca. 98-99 %. Representative analytical HPLC profile and MALDI-TOF mass spectrum of oligonucleotide 19a are shown in Figure 4a and 4b, respectively. In the mass spectrum molecular ion with m/z 5754 represents oligomer 19a (MW 5750), while a minute peak at m/z 5602 gives rise from [M-CH 2 CH 2 Thy] + fragmentation ion or decomposition product (Tp) 9 Y ab (pT) 9 .
Oligomers containing a 5'-DMT-protecting group and amidated BHPA units showed remarkable instability in MALDI-TOF experimental conditions due to the presence of the acid labile 5'-DMT protecting group and of the acid-labile amide P-N bond. A representative analytical HPLC profile and MALDI-TOF spectrum of oligonucleotide 19c are shown at Fig. 5a and 5b, respectively. The profile of analytical RP HPLC analysis shows exclusively one peak representing oligomer 19c and the MALDI-TOF mass spectrum confirms the presence of the expected product giving a signal at m/z 6053 (calc. 6051). However, due to instability of compound 19c in the conditions used for the MS analysis, oligomer 5'-DMT-(Tp) 9 Y(pT) 9 , where Y is BHPA-NH-CH 2 CH 2 Thy moiety, undergoes an acidic hydrolysis resulting in the appearance the three other products of the following MS signals: at m/z 5901 for product 5'-DMT-(Tp) 9 Y ab (pT) 9 (calc. 5900), at m/z 5751 for product (Tp) 9 Y(pT)9 (calc. 5749) and at m/z 5599 for product (Tp) 9 Y ab (pT) 9 (calc. 5598). Similar MALDI-TOF mass spectra were obtained for It has been proven that the more rigid structure of DNA analog (like e.g. LNA) provides better affinity to a complementary RNA strand. 22 From the other side peptide nucleic acid analogs (PNA) despite their structural flexibility exhibit extremely high affinity toward their DNA and RNA complements. 23 An interesting hybridization feature was found for oligomers 19a,c -21a,c with respect to their ability to form stable triplexes with hairpin DNA [d(A 21 C 4 T 21 )]. Melting temperatures of these triplexes (Table 3 ) are identical or slightly higher than that of the reference complexes. Probably the phosphinate / phosphate backbone flexibility of the third strand has less influence on triplex stability as compared to contribution of this feature in the duplex structure. (Table 2) , were used to study their recognition by 3′-and 5′-exonucleases. Chimeric oligonucleotides were incubated with snake venom (svPDE, PDE I) and with calf spleen phosphodiesterases (PDE II), respectively and the digestion products of each reaction were identified by MALDI-TOF mass spectrometry analysis. Figure 6a presents four subsequent MALDI-TOF mass spectra of degradation products of oligonucleotide 13 with PDE I taken after 10 min, 1, 2 and 3 hours of the cleavage reaction. A ladder of products, which differ by m/z 304, corresponds to the products of subsequent removal of pT nucleotides from the parent oligonucleotide 13 (m/z 5601). After 3 hours of cleavage reaction an accumulation of oligonucleotide (Tp) 9 Figure 6d ). In contrary, both these oligomers, 13 and 14, when treated with PDE II nuclease, result in accumulation of the products containing one natural nucleotide upstream of the modification site. Thus, oligomer 13 is subsequently degraded to product TpY ab (pT) 9 of m/z 3167 (Figure 6b ), while oligomer 14 results in the formation of compound TpY ab pY ab (pT) 9 of m/z 3354 (Figure 6d ).
Enzymatic degradation of chimeric oligomers 13 and 14 with 3′-and 5′-exonucleases as analyzed by MALDI-TOF technique
Snake venom phosphodiesterase, which is a 3′-exonuclease, is active up to the modification site being able to cleave the phosphodiester bond between thymidine and BHPA units. In contrast, calf spleen phosphodiesterase, which is a 5′-exonuclease, is not able to cleave the phosphodiester bond between 5'-thymidine and BHPA units. This nuclease removes all the 5′-terminal nucleotides but one upstream of the modification site. As expected, BHPA structural motives present in the DNA chain are resistant toward 3′-and 5′-exonucleases, however their recognition depends on the cleaving features of used nucleases. 24 ,25 Y ab units introduced at the ends of the oligomers can be a novel class of protecting "clamps" against cellular exonucleases and therefore can be used for protection of antisense, TFO, ribozyme and deoxyribozyme oligonucleotides tested in vivo or in cellular systems for their gene down-regulation activity. The added value of such protection is that BHPA abasic units located at the ends of the oligonucleotides demonstrate minimal influence on duplex stability, as it is shown in thermal stability of duplexes 15/dA 19 as well as for deoxyribozymes designed to cleave bcr-abl mRNA fragments in in vitro experiments. 8 Oligonucleotides 13 and 14 and the reference oligothymidylate T 20 were also given to the cleavage reaction with 3'-exonuclease from human plasma. 26 For this assay, 5′-radiolabeled oligonucleotides were incubated with 50 % human plasma. Products of degradation were analysed by PAGE under denaturing conditions (20 % polyacrylamide, 7 M urea). The results show that the reference oligomer incubated for 8 hours at 37 °C afforded a ladder of products ranging from T 19 to T 2 ( Figure 7a ). The chimeric oligomers were degraded only partially under these conditions. Degradation of oligonucleotide 13 proceeded from the 3'-terminus and was arrested by the presence of the abasic BHPA motif. As a consequence, accumulation of the product (Tp) 9 Y ab was observed (Figure 7b ). An analogous ladder of products, with accumulation of the product (Tp) 8 
Cytotoxicity of chimeric oligomers 17 and 18 towards HUVEC and HeLa cell lines
For determination of cytotoxicity of chimeric phosphinate / phosphate oligomers we chose two polyanionic oligomers 17 and 18. The cytotoxicity of the test oligomers was evaluated in tumor HeLa and endothelial HUVEC cell lines with an MTT assay. 27 Endothelial cells (HUVEC) were isolated and cultured as described. 28 HeLa cells were cultured according to the standard method.
As shown in Table 4 cytotoxicity of both polyanionic polymers toward tested cell lines was rather low. a Toxicity of oligomers was determined as described 27 by an MTT method. Absorbance of a given sample was measured at 570 nm, with the reference wavelength 630 nm (Microplate Reader 450, BioRad). The percentage of living cells (P LC ) was calculated from the equation: P LC = (A S -A M )/(A C -A M ) x 100 %, where As is the absorbance of a given sample of cells treated with oligomers, AM is the absorbance of a cell medium, Ac is the absorbance of a control (untreated) cells.
Conclusions
A series of novel DNA analogs, containing chimeric phosphinate / phosphate backbone could be effectively synthesized by incorporation of acylic nucleoside analogs derived from bishydroxymethylphosphinic acid (BHPA) residue into an oligonucleotide chain. Structural flexibility and loss of entropy make these chimeric oligomers unable to form stable duplexes with their complementary RNA and DNA strands. However, these oligomers possess slightly higher binding affinity towards double stranded DNA, as compared to a non-modified reference. Their low cytotoxic activity toward HUVEC and HeLa cell lines and, as expected, excellent stability toward 3'-and 5'-exonucleases does not preclude their use as therapeutic agents either as 3'-and 5'-terminal protecting groups or as triplex forming oligomers in antigene approach. Table 1 .
Phosphitylation of 8e
2-Cyanoethyl N,N-diisopropylphosphoramidochloridite (296 µL, 1.5 mmol) was added under argon to a solution of 8e (442 mg, 1 mmol) and ethyl-N,N-diisopropylamine (520 µL, 3 mmol) in anhydrous acenitrile (30 mL). The reaction mixture was kept for 2 h at room temperature and then applied under argon on a silica gel column. Loading of 8e on a LCA CPG solid support The solution of 8e (300 mg, 0.7 mmol), succinic anhydride (100 mg, 1.0 mmol) and 4-dimethylaminopyridine (110 mg, 0.9 mmol) in anhydrous pyridine (10 mL) were stirred for 24 hours at room temperature. After this time an additional portion of succinic anhydride (21 mg, 0.05 mmol) was added and the reaction mixture was kept for an additional 4 hours. Then chloroform was added to the reaction mixture, the organic phase was washed twice with 2 % aqueous citric acid (2x20 mL) and once with water (20 mL). The organic layer was dried with anhydrous magnesium sulfate, filtered and then evaporated to dryness. The acyl derivative of 8e was loaded on a silica gel column, eluted with CHCl 3 /MeOH 9:1 (v/v) and dried in vacuo. Long chain aminoalkyl control pore glass (LCA CPG, CHEMGENES, Ashland Technology Center, Ashland, MA) (2g) and acyl derivative of 8e (340 mg, 0.65 mmol) were dried overnight in vacuo, then dissolved in anhydrous DMF (10 mL) and pyridine (1 mL). DCC (250 mg, 1.2 mmol) was added to this solution and the reaction mixture was shaken for 48 hours at room temperature. Then the glass was washed with anhydrous methanol/pyridine (10 mL, 1:1, v/v) solution, with anhydrous acetonitrile (10 mL) and dried in vacuo. The loading efficiency was determined by DMT-cation assay. The modified solid support 9f was loaded with the derivative 8e up to 57.0 µmol /g.
Oligonucleotide synthesis
The 3'-O-phosphoramidite building units 9a-e were used for the synthesis of chimeric oligomers 10-21 by automated solid phase methodology. 14 The 1 µmole scale synthesis of oligomers was performed on an ABI 394 synthesizer (Applied Biosystems Inc., Foster City, CA) using succinyl-or oxalyl-linked LCAA-CPG solid support. The only difference in the manufacturer's recommended protocol was a prolonged coupling time (up to 600 s). The coupling efficiency was determined by DMT-ion assay. Oligomers 10c, 10d, 11 and 18 were synthesized on succinyl-linked LAC CPG as DMT OFF constructs, cleaved from the solid support by treatment with 28 % ammonium hydroxide (1mL) for 1 h at room temperature and purified by reverse phase semi-preparative HPLC.
Oligomers 12a, 12b, 19a-21a were synthesized on oxalyl-linked LCAA-CPG solid support as DMT OFF constructs. These oligomers were removed from the solid support by treatment with thiophenol / dioxane / triethylamine mixture (2:1:2, v/v) for 5 min at room temperature and then solid support was washes with 1 % aqueous triethylamine for 7-10 min at room temperature. After solvent evaporation oligomers were purified by semi-preparative or analytical HPLC (as indicated in table 2).
Oligomers 13-17, 19c-21c were obtained as the 5'-O-DMT protected constructs. These oligomers were purified by a standard RP HPLC method (DMT ON step). The removal of 5'-DMT group was achieved by treatment with 50 % acetic acid for 30 min at room temperature, followed by the RP HPLC semi-preparative purification (DMT OFF step) to produce fully deprotected oligonucleotides with 50-80 % yield.
The structure and purity of oligomers were confirmed by MALDI-TOF mass spectrometry, 20 % polyacrylamide / 7 M urea gel electrophoresis and RP HPLC analysis. 
Semi-preparative RP HPLC

MALDI-TOF measurements
Samples (1 µL) withdrawn from the digestion reactions were put on a sample plate, mixed with the matrix solution [1 µL of an 8/1, v/v mixture of 2,4,6-trihydroxyacetophenone (10 µg/mL in ethanol) and diammonium citrate (50 µg/mL in water)] and left for crystallization. MALDI-TOF spectra were recorded on a Voyager-Elite instrument (PerSeptive Biosystems, CT) in the reflector mode, at a resolution of 2000. M/z negative ion peaks are shown at the spectra.
Cell cultures
The Human epithelioid cervical carcinoma cell line (HeLa) was maintained in RPMI 1640 medium (Gibco BRL, Paisley, UK) supplemented with 10% thermally inactivated foetal bovine serum (FBS, Gibco BRL, Paisley, UK), 100 µg/mL streptomycin and 100 U/mL penicillin. Human umbilical vein endothelial cells (HUVEC) were isolated from freshly collected umbilical cords as previously described (Jaffe et al., 1973) , and cultured in plastic dishes coated with gelatin, in RPMI 1640 medium supplemented with 20% FBS, 90 U/ml heparin, 150µg/mL ECGF (Endothelial Cell Growth Factor, Roche Diagnostics, Mannheim, Germany) and antibiotics (as above). All cell lines were grown in monolayer, at 37°C in an atmosphere of 5% CO 2 .
